ProPublica

Journalism in the Public Interest

Cancel

Johnson & Johnson

Johnson & Johnson, based in New Brunswick, N.J., produces a wide range of consumer products, drugs and medical devices. Two of its divisions, Ortho-McNeil and Ortho-McNeil-Janssen, agreed to pay $81 million in April 2010 to settle civil and criminal charges of illegally promoting the epilepsy drug Topamax. The company has since renamed the divisions. In November 2013, the company also agreed to pay a $2.2 billion fine to resolve criminal and civil allegations relating to the prescription drugs Risperdal, Invega and Natrecor.

Johnson & Johnson is comprised of several subsidiaries that each report information separately. The subsidiaries in Dollars for Docs include Janssen Pharmaceuticals (the largest), Janssen Therapeutics, Janssen Biotech and Janssen Global Services. The units began reporting payments made in 2010 for speaking, consulting, post-marketing safety surveillance, meals and travel.

Each subsidiary reports on a different schedule, but in Dollars for Docs the payments are grouped together as Johnson & Johnson. The subsidiary is listed within each payment page.

See all Johnson & Johnson payments, or visit Johnson & Johnson's transparency page.

Notable drugs

Notable drugs from Janssen Biotech,
a subsidiary of Johnson & Johnson

  • Remicade (plaque psoriasis, rheumatoid arthritis, psoriatic arthritis, Crohn's disease/pediatric Crohn's disease, ankylosing spondylitis, ulcerative colitis/pediatric ulcerative colitis)
  • Procrit (anemia, reduction of allogeneic red blood cell transfusions in patients undergoing elective, noncardiac, nonvascular surgery)
  • Stelara (plaque psoriasis)
  • Simponi (rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis)
  • Zytiga (prostate cancer)

Notable drugs from Janssen Pharmaceuticals,
a subsidiary of Johnson & Johnson

Notable drugs from Janssen Therapeutics,
a subsidiary of Johnson & Johnson

Payment Reports

2010 Jan. to 2011 Dec., Janssen Global Services

Avg. Quarterly Total
Consulting $140,860 $140,860
$140,860 $140,860

2010 Jan. to Dec. Janssen Biotech

Avg. Quarterly Total
Speaking $725,175 $2,900,700
Consulting $156,047 $624,187
Other $44,204 $176,816
$925,426 $3,701,703

2010 Jan. to Dec. Janssen Pharmaceuticals

Avg. Quarterly Total
Speaking $1,684,425 $6,737,700
Combination $637,544 $2,550,175
Travel $393,540 $1,574,160
Consulting $205,318 $821,272
Meals $66,128 $264,512
Other $2,175 $8,700
$2,989,130 $11,956,519

2010 Jan. to Dec. Janssen Therapeutics

Avg. Quarterly Total
Speaking $500,125 $2,000,500
Consulting $84,125 $336,500
$584,250 $2,337,000

2011 Jan. to Dec. Janssen Biotech

Avg. Quarterly Total
Speaking $1,258,763 $5,035,050
Consulting $323,010 $1,292,039
Other $23,024 $92,097
$1,604,796 $6,419,186

2011 Jan. to Dec. Janssen Pharmaceuticals

Avg. Quarterly Total
Speaking $1,579,769 $6,319,075
Meals $1,101,540 $4,406,159
Consulting $486,550 $1,946,201
Travel $338,025 $1,352,098
Other $3,355 $13,419
$3,509,238 $14,036,952

2011 Jan. to Dec. Janssen Therapeutics

Avg. Quarterly Total
Speaking $682,188 $2,728,750
Consulting $49,038 $196,150
$731,225 $2,924,900

2012 Jan. to Dec. Janssen Global Services

Avg. Quarterly Total
Consulting $21,050 $84,200
$21,050 $84,200

2012 Jan. to Dec. Janssen Therapeutics

Avg. Quarterly Total
Speaking $420,638 $1,682,550
Consulting $24,694 $98,775
$445,331 $1,781,325

2012 Jan. to Dec. Janssen Pharmaceuticals

Avg. Quarterly Total
Speaking $2,826,281 $11,305,125
Meals $1,378,983 $5,515,932
Consulting $479,212 $1,916,850
Travel $430,020 $1,720,081
$5,114,497 $20,457,987

2012 Jan. to Dec. Janssen Biotech

Avg. Quarterly Total
Speaking $873,313 $3,493,250
Consulting $273,325 $1,093,300
$1,146,638 $4,586,550

Total Payments by State

State Total
California $7,977,506
New York $7,636,642
Florida $5,729,195
Texas $4,839,740
Pennsylvania $3,586,864
New Jersey $2,982,008
North Carolina $2,888,753
Illinois $2,716,692
Ohio $2,682,179
Michigan $2,287,747
Georgia $2,023,074
Massachusetts $1,465,659
Missouri $1,338,125
Puerto Rico $1,334,147
Maryland $1,310,964
Tennessee $1,293,871
Washington $1,215,039
Indiana $1,163,865
Connecticut $1,135,483
Arizona $1,108,775
Virginia $1,075,815
Alabama $1,021,446
Kentucky $920,870
South Carolina $807,453
Utah $769,126
Louisiana $611,323
Colorado $577,357
Nevada $566,812
District of Columbia $543,915
Wisconsin $514,538
Oregon $492,119
Oklahoma $485,900
Mississippi $428,487
Rhode Island $398,079
Minnesota $356,978
Kansas $323,336
Arkansas $221,922
New Hampshire $212,976
Iowa $212,817
West Virginia $199,877
Delaware $179,817
New Mexico $163,458
Nebraska $162,091
Idaho $105,080
Maine $99,838
Hawaii $91,598
Vermont $60,837
South Dakota $41,416
North Dakota $25,115
Wyoming $18,651
Montana $12,638
Alaska $9,170